Lv0
0 积分 2024-04-18 加入
A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release and ROS scavenging
1小时前
已完结
Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis
3天前
已完结
Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease
8天前
已完结
Polydopamine-coated ferric oxide nanoparticles for R848 delivery for photothermal immunotherapy in breast cancer
9天前
已完结
Tangeretin suppresses osteoarthritis progression via the Nrf2/NF-κB and MAPK/NF-κB signaling pathways
1个月前
已完结
Metabolic dysfunction-associated steatohepatitis treated by poly(ethylene glycol)-block-poly(cysteine) block copolymer-based self-assembling antioxidant nanoparticles
1个月前
已完结
Hepatic danger signaling triggers TREM2 + macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation
1个月前
已完结
Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseases
2个月前
已完结
Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice
3个月前
已完结
皖公网安备34019202002308
